Showing results (51-60 of 118) with videos related to
Sort By:
Pageof 12
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
First steps to creating a platform for high throughput simulation of TTFieldsHadas Sara Hershkovich, Zeev Bomzon, Cornelia Wenger, et al.International Journal of Molecular Sciences|December 30, 2025
Pro-Inflammatory Macrophage Phenotype Skewing Induced by Tumor Treating Fields (TTFields)Tal Kan, Yiftah Barsheshet, Tharwat Haj Khalil, et al.Cancer|April 19, 2016
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009Dorothee Gramatzki, Silvia Dehler, Elisabeth Jane Rushing, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)Thomas Ruhstaller, Miklos Pless, Daniel Dietrich, et al.European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Predictive value of radiological response, pathological response and relapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trialsRuncong Nie, Foping Chen, Mariano Provencio, et al.Medical Physics|May 13, 2020
Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patientsDiem Vuong, Marta Bogowicz, Sarah Denzler, et al.EJNMMI Research|August 21, 2021
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imagingCarol Oliveira, Florian Amstutz, Diem Vuong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2008
A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancerRodryg Ramlau, Elisabeth Quoix, Janusz Rolski, et al.BMC Cancer|July 25, 2024
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 studyTakaaki Tokito, Oleksii Kolesnik, Jens Sørensen, et al.British Journal of Cancer|April 17, 2019
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)Alessandra Curioni-Fontecedro, Jean Yannis Perentes, Hans Gelpke, et al.Pageof 12